newsfilter
← Earnings
Earnings Releases·

INVO Fertility — Third Quarter 2026 Earnings Summary

INVO Fertility reported third-quarter 2026 revenue of $2.22 million, representing a 26% increase from the prior year, driven by organic growth at existing clinics and contributions from the Indiana and Birmingham acquisitions. The company achieved positive Clinic-Level Adjusted EBITDA of $292,114 for the seventh consecutive quarter, despite a consolidated net loss of $2.1 million. Financial improvements included a strengthened balance sheet with cash reserves rising to $3.7 million and current liabilities decreasing to $4.5 million from $10.3 million at the end of 2025.

Company
INVO FERTILITY INC
Sector
Healthcare
Industry
Medical Devices